<img width="1280" height="720" src="https://cdn.slashgear.com/wp-content/uploads/2022/01/fda-building-1280×720.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="FDA sign near building" loading="lazy" style="margin: auto;margin-bottom: 5px;max-width: 100%" data-attachment-id="708843" data-permalink="https://www.slashgear.com/the-fda-rules-just-changed-on-covid-10-monoclonal-antibody-treatments-25708839/fda-building/" data-orig-file="https://cdn.slashgear.com/wp-content/uploads/2022/01/fda-building.jpg" data-orig-size="1600,900" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="fda-building" data-image-description="" data-image-caption="
JHVEPhoto/Shutterstock
” data-medium-file=”https://cdn.slashgear.com/wp-content/uploads/2022/01/fda-building-1280×720.jpg” data-large-file=”https://cdn.slashgear.com/wp-content/uploads/2022/01/fda-building-1280×720.jpg” />The U.S. Food and Drug Administration (FDA) has just released a new update in regards to the treatment options for COVID-19. As a result of the update, the FDA has removed the authorization for two monoclonal antibody treatments. Starting January 24, 2022, these treatments will only be authorized in certain regions. In the statement posted on FDA’s website, more information … Continue reading
Post a Comment